|Bid||29.96 x 900|
|Ask||29.97 x 1100|
|Day's range||29.52 - 30.50|
|52-week range||18.37 - 34.81|
|Beta (5Y monthly)||0.85|
|PE ratio (TTM)||N/A|
|Earnings date||07 May 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||33.82|
Elanco Animal Health Incorporated (NYSE: ELAN) will announce its first quarter 2021 financial results on Friday, May 7, 2021. Elanco will also conduct a conference call on that day with the investment community and media to further detail the company’s performance.
Today, let's look at three companies in this sector, Elanco (NYSE: ELAN), Trupanion (NASDAQ: TRUP), and IDEXX Laboratories (NASDAQ: IDXX), and how they can add both bark and bite to your portfolio. Elanco is a pharmaceutical company that develops medications and vaccines for pets and livestock.
Livestock farming has had its problems with greenhouse gas emissions, and the push for cleaner production has brought the need for innovations. Enter Elanco Animal Health (NYSE: ELAN), an animal pharmaceutical company that may have a new product that can help make farming more environmentally sustainable. Elanco has received approval for a drug called Experior that can reduce emissions for feedlot cattle.